Meniscus Tear in NYC: When PRP May Help You Avoid Surgery

The meniscus — a C-shaped pad of fibrocartilage between the femur and tibia — plays a critical role in load distribution, shock absorption, and joint stability. Meniscus tears are among the most common orthopaedic diagnoses in the United States, affecting athletes, active adults, and older patients alike. In New York City, where patients walk miles daily and maintain active lifestyles, knee health is a priority.

The conventional pathway for meniscal tears has historically defaulted to arthroscopic partial meniscectomy (APM) — surgical removal of the torn tissue. But growing evidence challenges that default. At Regen Health Physicians NYC, Dr. Ajit Dhaliwal offers PRP-based regenerative protocols as an alternative for appropriate candidates.

Types of Meniscus Tears and Healing Potential

Understanding why some tears heal and others don't begins with anatomy. The meniscus has two zones:

The Red Zone (Vascular Region)

The outer third of the meniscus has a blood supply and carries meaningful healing potential. Tears in this region — particularly in younger patients — may heal with conservative care or biological augmentation.

The White Zone (Avascular Region)

The inner two-thirds of the meniscus lacks direct vascularity. Without blood supply, the body cannot deliver reparative cells. Tears in this zone are traditionally considered non-healing and are more likely to be resected surgically.

PRP therapy attempts to bridge this healing deficit by delivering concentrated growth factors directly into or around the tear — providing the biological signals the tissue cannot generate independently.

What Does the Research Say?

Several clinical studies have examined PRP for meniscal pathology:

• A 2017 randomized trial in Knee Surgery, Sports Traumatology, Arthroscopy found that intralesional PRP injection during meniscus repair surgery significantly improved healing rates compared to repair alone.
• A 2020 review in Orthopaedic Journal of Sports Medicine concluded that PRP may reduce pain and improve function in degenerative meniscus tears, particularly in older patients not deemed candidates for surgery.
• Observational cohort data suggest that patients with Grade I–II meniscal tears who receive PRP report sustained functional improvements at 12-month follow-up.

The evidence base is growing but not definitive — patient selection, tear morphology, and concurrent joint health (especially the presence of osteoarthritis) significantly influence outcomes.

Who Is a Candidate for PRP?

Regenerative medicine is most appropriate for meniscal tears when:

• The tear is partial (not full-thickness through and through)
• The tear is in or near the vascular red zone
• The patient has not failed repeated conservative treatment
• There is no locked knee, severe mechanical symptoms, or large bucket-handle configuration requiring urgent decompression
• The patient wants to avoid or delay surgery

Patients with advanced osteoarthritis of the knee, locked joint symptoms, or complete root tears are generally better evaluated for surgical consultation first.

What RHPNY's Protocol Involves

Dr. Dhaliwal's regenerative knee program begins with a detailed history, physical examination, and review of MRI imaging. A 1.5T or 3T MRI is essential to classify the tear, assess concurrent chondral status, and rule out contraindications.

For appropriate candidates, ultrasound-guided PRP injection delivers concentrated autologous platelets to the perimeniscal tissue and tear interface. The procedure is performed in-office with local anesthesia and takes approximately 30–45 minutes. Most patients are ambulatory immediately and return to modified activity within days.

A structured rehabilitation protocol follows injection — protecting the tissue while promoting angiogenesis and cellular migration.

What to Expect

• Weeks 1–4: Reduced inflammation, improved range of motion
• Months 2–3: Meaningful pain reduction and functional gains in most responders
• Month 6: Repeat clinical assessment; MRI to evaluate tissue changes in selected cases

The Cost of Meniscectomy to Consider

Arthroscopic partial meniscectomy carries real risks: infection, anesthesia reactions, nerve damage, and — critically — accelerated cartilage loss. A landmark JAMA study (the METEOR trial) demonstrated that APM for degenerative meniscal tears offered no advantage over supervised exercise alone. Preserving meniscal tissue when possible is the preferred approach in evidence-based orthopedics.

Taking the Next Step

If you have a meniscus tear in NYC and want to explore whether regenerative medicine is appropriate, schedule a consultation with Dr. Dhaliwal at Regen Health Physicians. Our joint and orthopedic regenerative medicine service provides comprehensive evaluation. You can also review our joint-back orthopedic page for more information about our approach to musculoskeletal care.

Medical Disclaimer

This article is intended for educational purposes and does not constitute medical advice. PRP therapy for meniscus tears is an evolving field; outcomes are not guaranteed and depend on individual anatomy, tear characteristics, and patient health. Always consult with a qualified physician before making decisions about knee treatment.